Breaking Business News | Breaking business news AM | Breaking Business News PM

This seaweed extract outperforms COVID-19 drug remdesivir in the lab

27 Jul 2020

And it could be used to develop preventive treatments.

Remdesivir was the first major pharmaceutical breakthrough of the coronavirus pandemic: Research has found it’s able to help some patients recover faster from severe cases of the illness and may make it more likely that they survive. But a new study suggests that an extract from seaweed may outperform the drug.


Read the full article here.
This content was originally published by Fast Company. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fast Company

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.

Download